Fundz

StimOxyGen has raised £1.5M in funding to advance its cancer treatment development. The funding round was led by DSW Ventures, with co-investment from QUBIS and Co-Fund NI managed by Clarendon.

PRIVATEMar 11, 2025

Amount Raised

£1.5 Million

Round Type

Venture

ColeraineBiotechnologyHealth CareMedicalTherapeutics

Investors

DSW VenturesQubisCo Fund Ni

Description

StimOxyGen, a Derry, Northern Ireland-based company, raised £1.5M in funding. The round was led by DSW Ventures, with co-investment from QUBIS and Co-Fund NI. The company plans to use the funds to advance preclinical studies, scale-up manufacturing, and expand its team. This funding supports their goal of developing innovative cancer treatments that enhance the effectiveness of existing therapies.

Quick answer

StimOxyGen raised £1.5 Million in a funding round, dated March 11, 2025. Investors: DSW Ventures, Qubis and Co Fund Ni. StimOxyGen is based in Coleraine, Northern Ireland, United Kingdom.

How much did StimOxyGen raise?
StimOxyGen raised £1.5 Million in a funding round on March 11, 2025.
Who invested in StimOxyGen?
DSW Ventures, Qubis and Co Fund Ni are named as investors in this round.
What does StimOxyGen do?
StimOxyGen is a Derry, Northern Ireland-based company developing innovative cancer treatments that deliver oxygen directly to tumours.
Where is StimOxyGen based and how big is it?
StimOxyGen is based in Coleraine, Northern Ireland, United Kingdom. Fundz records about 3 employees.
Who are the decision-makers at StimOxyGen?
Fundz holds 1 contact at StimOxyGen. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical and Therapeutics around the same time

Companies in the same sectors as StimOxyGen that raised within 45 days of this round, from Fundz verified event records.

  • Lobe Sciences raised $6M (Series A) on April 14, 2025.
  • OncoNano Medicine raised $13M on April 11, 2025.
  • Accure Therapeutics S.L raised $1.6M (Seed) on April 7, 2025.
  • Lipella Pharmaceuticals raised $9K (Seed) on March 17, 2025.
  • Monument Therapeutics raised $1.1M (Seed) on February 25, 2025.
  • Solid IO raised $839K (Seed) on February 24, 2025.

Who to call at StimOxyGen, and when

A new round usually means StimOxyGen is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day StimOxyGen raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at StimOxyGen, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at StimOxyGen. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

StimOxyGen

Location

Coleraine, Northern Ireland, United Kingdom

About

StimOxyGen is a Derry, Northern Ireland-based company developing innovative cancer treatments that deliver oxygen directly to tumours. Led by a team of experts, including CEO Sian Farrell and CSO Professor Anthony McHale, the company aims to enhance the effectiveness of therapies such as radiotherapy and immunotherapy. Its lead candidate has shown promising results in reducing tumours when used in combination with radiotherapy across various cancer types. The company will initially focus on pancreatic cancer, which has limited treatment options and a low survival rate.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment StimOxyGen raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for StimOxyGen's next move

See what Strategic adds

StimOxyGen raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.